A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease progression.
Researchers have developed a way to print nanoparticles like ink, creating inexpensive sweat sensors that can continuously monitor multiple molecules.